Author

Luyi Wang

Children's Hospital of Chongqing Medical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Neuroscience· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Organism:Drosophila· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1

Frequent Co-Authors

Xiaoqin Zhou· 2 shared Ying Zhang· 2 shared Yongjun DangiD· 2 shared Catherine M. Daly· 1 shared Chengjie QiuiD· 1 shared Chuanjie Wang· 1 shared Dan Li· 1 shared Dion DickmaniD· 1 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Xiaoqin Zhou

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Homoharringtonine targets XPC to inhibit DNA damage repair and sensitize tumors to platinum-based chemotherapy

Chuanjie Wang, Ying Zhang, Xiaoqin Zhou, Jia He, Longjiang Liu, Luyi Wang, yanfang zhang, Qin Gong, Jiayu Zhang, Yongjun Dang, Jiaxue Wu

This paper identifies homoharringtonine as a DDR inhibitor that targets XPC to impair DNA repair and enhance platinum-based chemotherapy efficacy.

bioRxiv · Nov 1, 2026 · PreprintPharmacology & Toxicology

Resolving synaptic events using subsynaptically targeted GCaMP8 variants

Jiawen Carmen Chen, Junhao Lin, Kaikai He, Luyi Wang, Yifu Han, Chengjie Qiu, Jasmine M. Wheeler, Catherine M. Daly, Gregory T. Macleod, Dion Dickman

The paper introduces GCaMP8 variants targeted to synaptic compartments and develops CaFire software to quantify Ca2+ signals, showing improved sensitivity and resolution compared to existing methods.

eLife · Mar 2, 2026Peer-reviewedNeuroscience

p300/CBP-Driven Acetylation Stabilizes PARP7 to Reinforce Negative Feedback on IFN-I Signaling

Dan Li, Yao Liu, Ying Wang, Weijie Liu, Shihui Zhu, Ying Zhang, Luyi Wang, Xiaoqin Zhou, Wen Ding, Sanyong Zhu, Yongjun Dang, Jianmin Wu

This study identifies p300/CBP-mediated acetylation of PARP7 as a mechanism to suppress IFN-I signaling in tumor cells, with implications for enhancing antitumor immunity.

bioRxiv · Jan 30, 2026 · PreprintCancer Biology